|
The
following potentially dilutive securities have been excluded from the computation of diluted shares of common stock outstanding as they
would be anti-dilutive:
Schedule of Potentially Dilutive Securities
| |
|
2023 |
|
|
2022 |
|
| |
|
December
31, |
|
| |
|
2023 |
|
|
2022 |
|
| Common stock warrants August 2021 |
|
|
112,429 |
|
|
|
128,500 |
|
| Underwriter warrants August 2021 |
|
|
2,287 |
|
|
|
2,287 |
|
| Private warrants |
|
|
— |
|
|
|
90 |
|
| Chanticleer warrants |
|
|
57 |
|
|
|
57 |
|
| Series C warrants |
|
|
18,391 |
|
|
|
36,778 |
|
| Series 3 warrants |
|
|
12,548 |
|
|
|
12,548 |
|
| Unvested restricted stock units and awards |
|
|
7,840 |
|
|
|
10,002 |
|
| Common stock warrants February 2023 |
|
|
271,883 |
|
|
|
— |
|
| Underwriter warrants February 2023 |
|
|
15,466 |
|
|
|
— |
|
| Common stock private placement warrants June
2023 |
|
|
227,272 |
|
|
|
— |
|
| Placement agent warrants June 2023 |
|
|
6,818 |
|
|
|
— |
|
| Common stock warrants October 2023 |
|
|
5,687,500 |
|
|
|
— |
|
| Underwriter warrants October 2023 |
|
|
85,312 |
|
|
|
— |
|
| Total anti-dilutive weighted
average shares |
|
|
6,447,803 |
|
|
|
190,262 |
|
|